▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for PharmaCielo in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $1.30.
The current consensus among 1 polled investment analysts is to buy stock in PharmaCielo.
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis oil extracts, tetrahydrocannabinol, and related products to pharmacies, medical clinics, and cosmetic companies. The company also offers telemedicine software. It serves in Canada, Colombia, Italy, and Mexico. The company has a strategic alliance with AssuredTrans Inc. PharmaCielo Ltd. is headquartered in Toronto, Canada.